Interleukin‐17 is associated with expression of programmed cell death 1 ligand 1 in ovarian carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin‐17 is associated with expression of programmed cell death 1 ligand 1 in ovarian carcinoma
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume 110, Issue 10, Pages 3068-3078
Publisher
Wiley
Online
2019-08-21
DOI
10.1111/cas.14174
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic effect of programmed death-ligand 1 (PD-L1) in ovarian cancer: a systematic review, meta-analysis and bioinformatics study
- (2019) Lin Wang Journal of Ovarian Research
- Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
- (2018) Claudia Allemani et al. LANCET
- Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels
- (2018) LiJun Xu et al. Molecular Oncology
- Inflammatory cytokines IL-17 and TNF-α up-regulate PD-L1 expression in human prostate and colon cancer cells
- (2017) Xun Wang et al. IMMUNOLOGY LETTERS
- The Association of Peripheral Blood Regulatory T-Cell Concentrations With Epithelial Ovarian Cancer
- (2017) Rikki A. Cannioto et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- IL17 producing γδT cells induce angiogenesis and are associated with poor survival in gallbladder cancer patients
- (2016) Rushikesh Sudam Patil et al. INTERNATIONAL JOURNAL OF CANCER
- PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
- (2016) Junzo Hamanishi et al. International Journal of Clinical Oncology
- The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer
- (2016) Nan Zhang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer
- (2015) K Abiko et al. BRITISH JOURNAL OF CANCER
- Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor- B to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer
- (2015) J. Peng et al. CANCER RESEARCH
- Modulation of STAT3 and STAT5 activity rectifies the imbalance of Th17 and Treg cells in patients with acute coronary syndrome
- (2015) Yingxia Zheng et al. CLINICAL IMMUNOLOGY
- Decreased expression of IL-27 and its correlation with Th1 and Th17 cells in progressive multiple sclerosis
- (2015) Shao-can Tang et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Decreased IL-27 Negatively Correlated with Th17 Cells in Non-Small-Cell Lung Cancer Patients
- (2015) Minchao Duan et al. MEDIATORS OF INFLAMMATION
- Th17 cells and interleukin-17 increase with poor prognosis in patients with acute myeloid leukemia
- (2014) Yixiang Han et al. CANCER SCIENCE
- Development and function of interleukin 17-producing γδ T cells
- (2012) Thomas Korn et al. Annals of the New York Academy of Sciences
- IL-6, IL-17 and STAT3: a holy trinity in auto-immunity?
- (2012) Annalisa Camporeale Frontiers in Bioscience-Landmark
- Th17 cells in cancer: help or hindrance?
- (2011) Cailin Moira Wilke et al. CARCINOGENESIS
- Expression of Th17 Cells in Breast Cancer Tissue and Its Association with Clinical Parameters
- (2011) LiJuan Yang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Functional Specialization of Interleukin-17 Family Members
- (2011) Yoichiro Iwakura et al. IMMUNITY
- Distribution and Clinical Significance of Th17 Cells in the Tumor Microenvironment and Peripheral Blood of Pancreatic Cancer Patients
- (2011) Songbing He et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Global quantification of mammalian gene expression control
- (2011) Björn Schwanhäusser et al. NATURE
- IL-6: Regulator of Treg/Th17 balance
- (2010) Akihiro Kimura et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- STAT3 in CD4+ T helper cell differentiation and inflammatory diseases
- (2009) Charles E. Egwuagu CYTOKINE
- Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
- (2009) Sergei I. Grivennikov et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Morphine Disrupts Interleukin-23 (IL-23)/IL-17-Mediated Pulmonary Mucosal Host Defense against Streptococcus pneumoniae Infection
- (2009) J. Ma et al. INFECTION AND IMMUNITY
- IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway
- (2009) Lin Wang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients
- (2009) Jing-Ping Zhang et al. JOURNAL OF HEPATOLOGY
- Constitutive activation of signal transducer and activator of transcription 3 in epithelial ovarian carcinoma
- (2009) Hao Min et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses
- (2009) Shaoguang Wu et al. NATURE MEDICINE
- The prevalence of Th17 cells in patients with gastric cancer
- (2008) Bin Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Interleukin-17 Promotes Autoimmunity by Triggering a Positive-Feedback Loop via Interleukin-6 Induction
- (2008) Hideki Ogura et al. IMMUNITY
- IL-23/IL-17 Biology and Therapeutic Considerations
- (2008) Chen Dong Journal of Immunotoxicology
- Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer
- (2008) Y. Miyahara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now